Search results for " 2018" in Articles / App Notes

Article Biosimilars Will Bring Significant Litigation and Patent Challenges
Provided FDA begins approving antibody-based biosimilars, she expects to see an increase in litigation for these medications in 2018 or 2019. Sources: Nature GEN

Article Q&As with Industry Leaders
Mats Lundgren, Customer Applications Director at Cytiva State of the Biopharmaceutical Industry: Lessons from 2018 Survey Data …

Article Biotechnology Innovation and Growth in Israel
In 2011, Merck KGaA’s subsidiary Merck Serono invested US$13 million in a new drug development incubator with the goal of having at least six startups working on new medications or technologies by 201…

Show All Results

Previous Page